109 related articles for article (PubMed ID: 12583508)
21. Telomerase inhibitors.
Rowley PT; Tabler M
Anticancer Res; 2000; 20(6B):4419-29. PubMed ID: 11205282
[TBL] [Abstract][Full Text] [Related]
22. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
23. Role of telomerase in cell senescence and oncogenesis.
Urquidi V; Tarin D; Goodison S
Annu Rev Med; 2000; 51():65-79. PubMed ID: 10774453
[TBL] [Abstract][Full Text] [Related]
24. Gossypol: a potential antifertility agent for males.
Qian SZ; Wang ZG
Annu Rev Pharmacol Toxicol; 1984; 24():329-60. PubMed ID: 6375548
[TBL] [Abstract][Full Text] [Related]
25. Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway.
Kelland L
Clin Cancer Res; 2007 Sep; 13(17):4960-3. PubMed ID: 17785545
[TBL] [Abstract][Full Text] [Related]
26. Telomere biology of pediatric cancer.
Tabori U; Dome JS
Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
[TBL] [Abstract][Full Text] [Related]
27. Mutated telomeres sensitize tumor cells to anticancer drugs independently of telomere shortening and mechanisms of telomere maintenance.
Cerone MA; Londoño-Vallejo JA; Autexier C
Oncogene; 2006 Nov; 25(56):7411-20. PubMed ID: 16767163
[TBL] [Abstract][Full Text] [Related]
28. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity.
Ouchi H; Ishiguro H; Ikeda N; Hori M; Kubota Y; Uemura H
Int J Urol; 2005 Jan; 12(1):73-80. PubMed ID: 15661057
[TBL] [Abstract][Full Text] [Related]
29. Telomerase modulation in therapeutic approach.
Romaniuk A; Kopczynski P; Ksiazek K; Rubis B
Curr Pharm Des; 2014; 20(41):6438-51. PubMed ID: 24975610
[TBL] [Abstract][Full Text] [Related]
30. Telomerase inhibitors in cancer therapy: current status and future directions.
Incles CM; Schultes CM; Neidle S
Curr Opin Investig Drugs; 2003 Jun; 4(6):675-85. PubMed ID: 12901225
[TBL] [Abstract][Full Text] [Related]
31. Telomere maintenance mechanisms as a target for drug development.
Bearss DJ; Hurley LH; Von Hoff DD
Oncogene; 2000 Dec; 19(56):6632-41. PubMed ID: 11426649
[TBL] [Abstract][Full Text] [Related]
32. Activation of human telomerase reverse transcriptase expression by some new symmetrical bis-substituted derivatives of the anthraquinone.
Huang HS; Chiou JF; Fong Y; Hou CC; Lu YC; Wang JY; Shih JW; Pan YR; Lin JJ
J Med Chem; 2003 Jul; 46(15):3300-7. PubMed ID: 12852760
[TBL] [Abstract][Full Text] [Related]
33. Multiple pathways for the regulation of telomerase activity.
Holt SE; Wright WE; Shay JW
Eur J Cancer; 1997 Apr; 33(5):761-6. PubMed ID: 9282114
[TBL] [Abstract][Full Text] [Related]
34. Telomeres, telomerase and cancer: is the magic bullet real?
Sharma HW; Maltese JY; Zhu X; Kaiser HE; Narayanan R
Anticancer Res; 1996; 16(1):511-5. PubMed ID: 8615664
[TBL] [Abstract][Full Text] [Related]
35. Telomerase as a new target for pancreatic cancer treatment.
Sato N; Mizumoto K; Nagai E; Tanaka M
J Hepatobiliary Pancreat Surg; 2002; 9(3):322-7. PubMed ID: 12353143
[TBL] [Abstract][Full Text] [Related]
36. [The role of telomere-binding proteins in carcinogenesis].
Aragona M; Pontoriero A; Panetta S; La Torre I; La Torre F
Minerva Med; 2000; 91(11-12):299-304. PubMed ID: 11253711
[TBL] [Abstract][Full Text] [Related]
37. Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo.
Lin J; Wu Y; Yang D; Zhao Y
Oncol Rep; 2013 Aug; 30(2):731-8. PubMed ID: 23708869
[TBL] [Abstract][Full Text] [Related]
38. Biochemical correlates of the antitumor and antimitochondrial properties of gossypol enantiomers.
Benz CC; Keniry MA; Ford JM; Townsend AJ; Cox FW; Palayoor S; Matlin SA; Hait WN; Cowan KH
Mol Pharmacol; 1990 Jun; 37(6):840-7. PubMed ID: 2193225
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of human telomerase activity by alterperylenol.
Togashi K; Kakeya H; Morishita M; Song YX; Osada H
Oncol Res; 1998; 10(9):449-53. PubMed ID: 10223620
[TBL] [Abstract][Full Text] [Related]
40. Imetelstat (GRN163L)--telomerase-based cancer therapy.
Röth A; Harley CB; Baerlocher GM
Recent Results Cancer Res; 2010; 184():221-34. PubMed ID: 20072842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
